AndrewMSiedleckiMD

Nephrology • Saint Petersburg, FL

Kidney & Pancreas Transplantation, Renovascular Medicine

Instructor in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Siedlecki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Siedlecki's full profile

Already have an account?

Office
1201 5th Ave N
Ste 302
Saint Petersburg, FL 33705
Phone+1 727-821-2388

Fax+1 727-821-6887

Clinical Expertise

Transplant nephrology

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 2006 - 2009
University of Alabama Medical CenterResidency, Internal Medicine, 2003 - 2006
University of South Florida College of MedicineClass of 2003

Certifications & Licensure

FL State Medical License 2008 - 2025
MA State Medical License 2011 - 2024
MO State Medical License 2009 - 2012
AL State Medical License 2005 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation Start of enrollment: 2013 Nov 01
Terminated
Phase 2
Ravulizumab and COVID-19 Start of enrollment: 2020 Dec 18
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

98 citations
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.
Franz Schaefer, Gianluigi Ardissino, Gema Ariceta, Fadi Fakhouri, Marie Scully
Kidney International. 2018-08-01
82 citations
Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.
Andrew M. Siedlecki, Xiaohua Jin, Anthony J. Muslin
Kidney International. 2009-04-02
465 citations
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.
Benjamin S. Freedman, Craig R. Brooks, Albert Q. Lam, Hongxia Fu, Ryuji Morizane
Nature Communications. 2015-10-23

Journal Articles

miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature
Steven L Chang, Graeme Steele, Adam S Kibel, Andrew M Siedlecki, The American Journal of Pathology

Lectures

Recognizing and Managing Atypical Hemolytic Uremic Syndrome in Complex Clinical Settings
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019

Press Mentions

New Data from Global aHUS Registry Presented at ASN 2016 Show a Three-Fold Reduction in Post-Transplant Dialysis in Patients Initiating Soliris® (Eculizumab) Treatment Prior to Transplant Compared to Initiating Treatment Post-TransplantNovember 17th, 2016